Novel Targets for Alzheimer’s Disease Treatment: Medin and PLD3
Nina Culum2023-03-27T14:52:16-04:00News, Scientific Articles|
Given that Alzheimer's disease is multifactorial and heterogenous, drug development progress is more likely to occur if multiple pathways are considered. Two recent Nature publications have potentially identified medin and PLD3 as new targets for Alzheimer’s disease treatment, which we summarize in this mini-review.
Featured Webinars
Evaluation of TruVivo, an All-Human Hepatocyte Model for Mechanistic DMPK Investigations
Tuesday, June 20, 2023
Sponsor: LifeNet Health LifeSciences
Partner: Scientist.com
The Heat is On: A Technical Overview of Animal Warming
Wednesday, June 21, 2023
Sponsor: Kent Scientific Corporation
Real-time IntraVital Microscopy (IVM): In Vivo Live Cell Imaging in Immunology and Neuroscience with Live Imaging Demo
Thursday, June 22, 2023
Webinar Host: IVIM Technology Inc.
Advertisement
Latest News & Resources
What does exercise do for the brain?
June 9, 2023
Conference Content: American Physiology Summit 2023
June 2, 2023
Video Interview – IonOptix MultiCell Sytem
May 31, 2023
Content Categories
Aging
Analytical Sciences
Animal Behavioral Neuroscience
Auditory Sciences
Cancer & Oncology Research
Cardiovascular
Cell & Molecular Biology
Clinical Research
Drug Discovery & Development
Education & Teaching
Epidemiology & Infectious Disease
General Biology
Genetics & Genomics
Human Physiology
Industry & Career
Lab Animal Sciences
Materials Science
Metabolic Function
Microbiology & Immunology
Microscopy
Muscle Physiology & Function
Neuroscience
Obesity
Pharmacology
Preclinical Imaging
Renal Physiology
Respiratory Science
Sports Science
Toxicology
Value, Evidence, Access
Vascular Biology
Vision Research